Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 607

Showing 1-25 of 607 citing articles:

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 721
Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
Julianne D. Twomey, Baolin Zhang
The AAPS Journal (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 506
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Kyoko Oura, Asahiro Morishita, Joji Tani, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5801-5801
Open Access | Times Cited: 309
Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity
Joy X. Wang, Stephen Yiu Chuen Choi, Xiaojia Niu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8363-8363
Open Access | Times Cited: 276
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 259
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Mana Taki, Kaoru Abiko, Masayo Ukita, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 17, pp. 4669-4679
Open Access | Times Cited: 234
Understanding the tumor microenvironment for effective immunotherapy
Habib Sadeghi Rad, James Monkman, Majid Ebrahimi Warkiani, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1474-1498
Open Access | Times Cited: 230
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Aadhya Tiwari, Rakesh Trivedi, Shiaw‐Yih Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 207
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities
Stephen P. Hack, Andrew X. Zhu, Yulei Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 201
TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy
Lingyun Li, Xia Liu, Katherine L. Sanders, et al.
Cell Metabolism (2018) Vol. 29, Iss. 1, pp. 103-123.e5
Open Access | Times Cited: 190
Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
Mihaela Aldea, Fabrice André, Aurélien Marabelle, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 874-899
Open Access | Times Cited: 186
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
Yang Woo Kwon, Han-Seul Jo, Sungwon Bae, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 183
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 180
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Carlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 160
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
Lihua Chen, Lixiang Huang, Yu Gu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11943-11943
Open Access | Times Cited: 158
A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
Xuan Wang, Yingqi Liu, Chencheng Xue, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 140
IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
Bo Hu, Mincheng Yu, Xiaolu Ma, et al.
Cancer Discovery (2022) Vol. 12, Iss. 7, pp. 1718-1741
Open Access | Times Cited: 127
Cancer immunotherapy: it’s time to better predict patients’ response
Charlotte Pilard, Marie Ancion, Philippe Delvenne, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 7, pp. 927-938
Open Access | Times Cited: 126
A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors
Lingxiao Zhang, Jing Zhao, Xi Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Closed Access | Times Cited: 118
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells
Shoubao Ma, Baofa Sun, Songqi Duan, et al.
Nature Immunology (2023) Vol. 24, Iss. 2, pp. 255-266
Open Access | Times Cited: 111
Chronic inflammation, cancer development and immunotherapy
Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 96
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 90
Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
Huiqun Huang, Ronghui Liu, Jie Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1868-1868
Open Access | Times Cited: 73
Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 70
Immuno-photodynamic Therapy (IPDT): Organic Photosensitizers and Their Application in Cancer Ablation
Lu Yang, Wen Sun, Jianjun Du, et al.
JACS Au (2023) Vol. 3, Iss. 3, pp. 682-699
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top